Prof Paola Patrignani speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the use of aspirin for colorectal cancer prevention.

She outlines her studies which look at using low dose aspirin to reduce the chance of mutagenesis and metastases.

Prof Patrignani briefly explains some preexisting guidelines, but also the research needed to further develop and clarify these dosages.

Read more about the conference here.